Who are the healthcare predictive analytics companies?

The leading healthcare predictive analytics companies in 2026 are Health Catalyst, Innovaccer, Arcadia, Clarify Health, Komodo Health, Inovalon, Cotiviti, and Vizier. The category splits by use case — readmission prediction (Epic-native, Vizier, Health Catalyst), sepsis early warning (Epic Deterioration Index, Bayesian Health), population risk stratification (Arcadia, Innovaccer, Clarify, Vizier), Star Ratings projection (Inovalon, Cotiviti, Vizier), FWA detection (Cotiviti, Optum, SAS), and patient-journey / real-world evidence (Komodo, Truveta, IQVIA).

Healthcare predictive analytics is not a single category — it's a collection of specialised use cases that different vendors lead in. Readmission prediction has both EHR-native solutions (Epic readmission risk score, Cerner SafetyNet) and dedicated analytics (Vizier LACE+ / HOSPITAL implementations). Sepsis early warning was traditionally Epic Deterioration Index territory; Bayesian Health and others have built FDA-cleared alternatives. Population risk stratification is the territory of the four major ACO / pop-health platforms. Stars projection is dominated by the payer-side specialists. Each use case has 3-5 strong vendors and many weaker ones; the right choice rarely comes from a single "best healthcare predictive analytics company" list — it comes from matching the use case to the right specialist.

The most over-marketed claim in healthcare predictive analytics is the implication that better models drive better outcomes. The evidence consistently shows the opposite — outcome improvement depends almost entirely on what happens after the prediction is generated, not on model accuracy. A sepsis early warning model with 90% sensitivity that is ignored 80% of the time by nursing because the alerts are noisy or untrustworthy produces no clinical improvement. A simpler model with 75% sensitivity routed cleanly to a rapid response team that responds within 10 minutes produces measurable mortality reduction. Buyers evaluating predictive analytics should weight workflow integration and clinician trust at least as heavily as model AUC.

Three questions distinguish vendors worth evaluating from vendors that look impressive in demos but don't deliver in production. First, can the vendor produce a study from a real customer showing outcome improvement attributable to their predictions (not just model performance metrics)? Second, does the prediction route to operational workflow — care manager task list, rapid response team alert, Stars intervention plan — or does it stop at a dashboard? Third, is the model explainable to the clinician or care manager seeing the alert? Black-box scores get ignored after the first false-positive cluster. Disclosed models with feature contributions get acted on.